Tumblr Fave Likes Y...
Health Care: Drugs
Pharmacyclics Incorporated (PCYC: NASDAQ)
$81.86 -3.03 | -3.57%
05/20/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:73.15
Price Earnings Comparisons:
| PCYC | Sector Avg. | S&P 500 |
|---|---|---|
| 73.15 | 73.20 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -2.43 | 190.90 | 1095.63 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 895.90 | 0.00 | 0.00 |
| Net Income | -1.51 | 0.00 | |
| EPS | -1.19 | 0.00 |
Earnings for PCYC:
| EBITDA | 11.88M |
| REVENUE | 81.99M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.07 | $-0.16 | $-0.35 | $-0.57 |
| Number of Analysts | 5 | 8 | 9 | 10 |
| High Estimate | $0.00 | $0.35 | $1.94 | $1.39 |
| Low Estimate | $-0.23 | $-0.46 | $-1.61 | $-3.14 |
| Prior Year | $-0.24 | $1.02 | $0.17 | $-0.35 |
| Growth Rate (Year over Year) | 72.50% | -115.69% | -306.54% | -62.91% |
Portfolios with PCYC
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 28
- UserGFNN Stockdiagnostics 20
- ContributorStocks Rising On Unusual Vo...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Best-Performing Stocks i...
- ContributorStocks At New 52-Week Highs...
Latest PCYC Headlines from TheStreet
- Pharmacyclics Incorporated (PCYC): Drugs' Featured Daily Laggard 04.09.13 | 05:04 pm
- TheStreet Ratings Top 10 Rating Changes 04.08.13 | 09:04 am
- Pharmacyclics Incorporated Stock Downgraded (PCYC) 04.05.13 | 05:04 am
- Pharmacyclics Incorporated (PCYC): Today's Featured Drugs Laggard 03.19.13 | 05:03 pm
- INCY, PCYC, EW And A, 4 Health Care Stocks Pushing The Sector Lower 03.19.13 | 01:03 pm
- Pharmacyclics Incorporated (PCYC): Today's Featured Health Care Laggard 03.08.13 | 05:03 pm
- 5 Stocks Pushing The Health Care Sector Higher 03.06.13 | 12:03 pm
- Pharmacyclics Stock Hits New 52-Week High (PCYC) 03.05.13 | 10:03 am
- Pharmacyclics Reaches New 52-Week High (PCYC) 02.20.13 | 01:02 pm
- Pharmacyclics Rises On Unusually High Volume (PCYC) 02.13.13 | 03:02 pm
Press Releases for PCYC
- Pharmacyclics Announces Date Of Financial Results For Three Months Ended March 31, 2013 And Conference Call - PR Newswire 04.24.13 | 04:04 pm
- Pharmacyclics Completes Enrollment Of First Phase III Ibrutinib CLL Study - RESONATEâ¿¢ And Announces Completion Of Enrollment Of Phase II Ibrutinib MCL Study - SPARK - PR Newswire 04.18.13 | 04:04 pm
- Pharmacyclics Triggers Fourth Milestone Payment For Enrollment Of 5th Patient In Frontline Phase III CLL Study - PR Newswire 04.11.13 | 06:04 am
- Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid And Sustainable Disease Control Irrespective Of Age Or High Risk Prognostic Factor - PR Newswire 04.08.13 | 01:04 pm
- Pharmacyclics Announces Third Breakthrough Therapy Designation For Ibrutinib From The U.S. Food And Drug Administration - PR Newswire 04.08.13 | 06:04 am
- Pharmacyclics, Inc. Prices Public Offering Of Common Stock - PR Newswire 03.08.13 | 08:03 am
- Pharmacyclics, Inc. Announces Proposed Public Offering Of Common Stock - PR Newswire 03.07.13 | 04:03 pm
- Pharmacyclics First To Announce Breakthrough Therapy Designation In Oncology From The U.S. Food And Drug Administration - PR Newswire 02.12.13 | 07:02 pm
- Pharmacyclics Announces Date Of Financial Results For Three And Six Months Ended December 31, 2012 And Conference Call - PR Newswire 02.07.13 | 04:02 pm
- Pharmacyclics® Announces Updated Results For BTK Inhibitor Ibrutinib (PCI-32765) At American Society Of Hematology (ASH) Annual Meeting - PR Newswire 12.11.12 | 04:12 pm
Partner Headlines for PCYC
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- Pharmacyclics Is Ripe For A Major Correction - Seeking Alpha 02.16.13 | 06:02 am
- UPDATE: Dawson James Initiates Pharmacyclics at Market Outperform on Ibrutinib Confidence - Benzinga 12.07.12 | 09:12 am
- Celgene, Regeneron Pharmaceutical Lead Biomed Group - Investor's Business Daily 11.30.12 | 05:11 pm
- Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) - Benzinga 11.12.12 | 01:11 pm
- Benzinga's Top Initiations - Benzinga 11.01.12 | 09:11 am
- The Breakthrough At Northwest Biotherapeutics - Seeking Alpha 10.18.12 | 09:10 am
- Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN) - Benzinga 09.26.12 | 01:09 pm
- Pharmacyclics Earns Milestone - Analyst Blog - NASDAQ 08.24.12 | 07:08 pm
